cardiac MRI, biomarkers, Cardiovascular disease, cardiomyopathy,

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect that heart and vessels such as coronary artery disease, stroke, hypertension and peripheral artery disease. Another class of cardiovascular diseases that have received a lot of attention in the last decade are rare CVDs (RCD) that affect few people and include conditions such as Fabry disease (FD), cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM).

Feb. 12, 2026 — ACIST Medical Systems, Inc., a Bracco Group company, has announced the launch in selected markets in Europe of the ACIST Pro Diagnostic System, a next-generation variable-rate contrast management solution designed to advance precision, safety and efficiency in image-guided cardiovascular procedures.

Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This acquisition is a critical step for CellProthera as it prepares to enter the pivotal Phase 3 clinical trial.  The transendocardial catheter is a key enabling technology of its therapeutic approach, delivering targeted application of proprietary processed CD34 + stem cells directly into damaged cardiac tissue.

Feb. 11, 2026 – Columbia HeartSource, an extension of Columbia University Irving Medical Center’s Department of Surgery and Division of Cardiology and Corazon, a national leader in strategic program development for cardiovascular services, have partnered to deliver unique accreditation services for open-heart surgery programs nationwide.

Feb. 11, 2026 — The Northwestern Medicine Bluhm Cardiovascular Institute (BCVI) in Chicago has received a $50 million from philanthropist Neil G. Bluhm and the Bluhm Family Foundation. The gift builds on two decades of generosity from Bluhm, bringing his total gifts to BCVI to $135 million.

Feb. 5, 2026 — New research shows that the use of an AI-enabled digital stethoscope more than doubled the identification of moderate to severe valvular heart disease during routine clinical examinations, compared to a traditional stethoscope.

Feb. 4, 2026 — Acclaimed actor and philanthropist Jeremy Renner will serve as the closing speaker at the HIMSS Global Health Conference & Exhibition, March 9-12 at the Venetian Convention and Expo Center in Las Vegas.

Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVER 13 achieved superior brain tissue reperfusion with an excellent safety profile when compared with medical management in medium vessel occlusion (MVO) stroke. The findings were presented at the 2026 International Stroke Conference (ISC).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now